DR30303

DR30303 · Zhejiang Doer Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DR30303, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors [Phase 1]

See pricing